These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9623118)

  • 41. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of medication-associated initiation of oxybutynin in elderly men and women.
    Kalisch Ellett LM; Pratt NL; Barratt JD; Rowett D; Roughead EE
    J Am Geriatr Soc; 2014 Apr; 62(4):690-5. PubMed ID: 24635879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
    Gish P; Mosholder AD; Truffa M; Johann-Liang R
    J Pediatr; 2009 Sep; 155(3):432-4. PubMed ID: 19732583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
    Wang AC; Chih SY; Chen MC
    Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of anticholinergic drugs on attention span and short-term memory skills in children.
    Giramonti KM; Kogan BA; Halpern LF
    Neurourol Urodyn; 2008; 27(4):315-8. PubMed ID: 17828786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of controlled-release delivery on the pharmacokinetics of oxybutynin at different dosages: severity-dependent treatment of the overactive bladder.
    Preik M; Albrecht D; O'Connell M; Hampel C; Anderson R
    BJU Int; 2004 Oct; 94(6):821-7. PubMed ID: 15476516
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxybutynin-induced reflux esophagitis.
    Lee M; Sharifi R
    DICP; 1990 Jun; 24(6):583-5. PubMed ID: 2360335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Overdose of anticholinergic agents and confusional syndrome].
    Choulot JJ; Mensire A; Saint Martin J
    Ann Pediatr (Paris); 1989 Dec; 36(10):714. PubMed ID: 2624388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transdermal oxybutynin for overactive bladder.
    Davila GW; Starkman JS; Dmochowski RR
    Urol Clin North Am; 2006 Nov; 33(4):455-63, viii. PubMed ID: 17011381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxybutynin: is it safe?
    Baigrie RJ; Kelleher JP; Fawcett DP; Pengelly AW
    Br J Urol; 1988 Oct; 62(4):319-22. PubMed ID: 3191355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is attempting suicide an adverse effect of oxybutynin in a child with enuresis nocturna?
    Coskun S; Yüksel H; Onag A
    Pediatr Emerg Care; 2001 Oct; 17(5):398. PubMed ID: 11673723
    [No Abstract]   [Full Text] [Related]  

  • 55. Epistaxis as a side effect of oxybutynin in children: report of two cases.
    Batista JE; Caffaratti J; Garat JM
    Neurourol Urodyn; 1994; 13(1):85-6. PubMed ID: 8156079
    [No Abstract]   [Full Text] [Related]  

  • 56. Plasma levels of oxybutynine chloride in children.
    Autret E; Jonville AP; Dutertre JP; Bertiere MC; Robert M; Averous M; Couet W
    Eur J Clin Pharmacol; 1994; 46(1):83-5. PubMed ID: 8005192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of systematic treatment based on overnight simultaneous monitoring of electroencephalography and cystometry.
    Kawauchi A; Imada N; Tanaka Y; Yamao Y; Watanabe H
    Eur Urol; 1998; 33 Suppl 3():58-61. PubMed ID: 9599741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. S-oxybutynin.
    Drugs R D; 2002; 3(2):84-5. PubMed ID: 12001823
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute-angle closure glaucoma as a side-effect of oxybutynin.
    Sung VC; Corridan PG
    Br J Urol; 1998 Apr; 81(4):634-5. PubMed ID: 9598644
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychotic disorder induced by oxybutynin: Presentation of two cases.
    Gulsun M; Pinar M; Sabanci U
    Clin Drug Investig; 2006; 26(10):603-6. PubMed ID: 17163294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.